📣 VC round data is live. Check it out!
- Public Comps
- IMCD
IMCD Valuation Multiples
Discover IMCD's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Viohalco, Celanese, Sumitomo Chemical, Mitsubishi Gas Chemical and more.
IMCD Overview
About IMCD
IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two categories: Life Science consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care and I&I, and The Industrial segment contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment.
Founded
1995
HQ

Employees
5.1K
Website
Sectors
Financials (LTM)
EV
$8B
Valuation Multiples
Start free trialIMCD Financials
IMCD reported last 12-month revenue of $6B and EBITDA of $644M.
In the same LTM period, IMCD generated $1B in gross profit, $644M in EBITDA, and $300M in net income.
Revenue (LTM)
IMCD P&L
In the most recent fiscal year, IMCD reported revenue of $6B and EBITDA of $633M.
IMCD is profitable as of last fiscal year, with gross margin of 25%, EBITDA margin of 11%, and net margin of 5%.
Financial data powered by Morningstar, Inc.
IMCD Stock Performance
IMCD has current market cap of $6B, and enterprise value of $8B.
Market Cap Evolution
IMCD's stock price is $104.93.
IMCD share price increased by 1.9% in the last 30 days, and decreased by 20.3% in the last year.
IMCD has an EPS (earnings per share) of $4.36.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8B | $6B | 2.0% | 1.9% | -0.7% | -20.3% | $4.36 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIMCD Valuation Multiples
IMCD trades at 1.4x EV/Revenue multiple, and 12.3x EV/EBITDA.
EV / Revenue (LTM)
IMCD Financial Valuation Multiples
As of June 3, 2026, IMCD has market cap of $6B and EV of $8B.
IMCD has a P/E ratio of 20.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified IMCD Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


IMCD Margins & Growth Rates
IMCD grew revenue by 5% and EBITDA by 4% in the last fiscal year.
In the most recent fiscal year, IMCD reported gross margin of 25%, EBITDA margin of 11%, and net margin of 5%.
IMCD Margins
IMCD Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
IMCD Operational KPIs
IMCD's revenue per employee in the last FY averaged $1.1M, while opex per employee averaged $0.2M for the same period.
IMCD's Rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
IMCD's Rule of X is 28% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
IMCD Competitors
IMCD competitors include Viohalco, Celanese, Sumitomo Chemical, Mitsubishi Gas Chemical, SOL, Axalta Coating Systems, Wacker Chemie, Luberef, UPL and Bachem.
Most IMCD public comparables operate across Chemicals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.0x | - | 9.7x | - | |||
| 1.8x | 1.8x | 9.1x | 8.6x | |||
| 0.7x | 0.8x | 8.8x | 6.5x | |||
| 1.5x | 1.5x | 12.4x | 13.4x | |||
| 3.1x | 3.0x | 12.2x | 11.7x | |||
| 1.8x | 1.8x | 8.0x | 8.0x | |||
| 1.1x | 1.1x | 13.8x | 11.3x | |||
| 2.6x | 2.3x | 17.8x | 14.0x | |||
This data is available for Pro users. Sign up to see all IMCD competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by IMCD
IMCD has acquired 35 companies to date.
Last acquisition by IMCD was on October 16th 2025. IMCD acquired Dong Yang FT for undisclosed valuation.
Latest Acquisitions by IMCD
| Description | Dong Yang FT is a South Korean provider of cosmetic raw materials and ingredients. Osan-based, it supplies functional actives, emulsifiers, and preservatives to manufacturers in Asia. The company collaborates on custom formulations for skincare and makeup products meeting global regulatory standards. | Tillmanns is a Milan-based distributor of specialty chemicals and raw materials serving food processing, water treatment, and coatings industries in Italy. Founded in 1924, it supplies enzymes, antimicrobials, and polymers from BASF and Dow to 1,000 manufacturers. Tillmanns operates warehouses in Lombardy stocking 5,000 SKUs with just-in-time delivery across southern Europe. | Apus QuÃmica is a Santiago-based manufacturer of performance chemicals tailored for rubber, plastics, and chemical industries in Chile, providing specialized additives and compounds to optimize processing and end-product durability. | Tecom Ingredients is a Girona-based supplier of functional ingredients and additives for the food and beverage industry in Spain. The company provides emulsifiers, stabilizers, flavors, and preservatives to manufacturers of dairy, bakery, and confectionery products across Europe. | |
| HQ Country | |||||
| HQ City | Seoul | Milan | Santiago | Barcelona | |
| Deal Date | 16 Oct 2025 | 27 Aug 2025 | 30 Jun 2025 | 16 May 2025 | |
| Valuation | undisclosed | $154M | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all IMCD acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout IMCD
| When was IMCD founded? | IMCD was founded in 1995. |
| Where is IMCD headquartered? | IMCD is headquartered in Netherlands. |
| How many employees does IMCD have? | As of today, IMCD has over 5K employees. |
| Is IMCD publicly listed? | Yes, IMCD is a public company listed on Euronext Amsterdam. |
| What is the stock symbol of IMCD? | IMCD trades under IMCD ticker. |
| When did IMCD go public? | IMCD went public in 2014. |
| Who are competitors of IMCD? | IMCD main competitors include Viohalco, Celanese, Sumitomo Chemical, Mitsubishi Gas Chemical, SOL, Axalta Coating Systems, Wacker Chemie, Luberef, UPL, Bachem. |
| What is the current market cap of IMCD? | IMCD's current market cap is $6B. |
| What is the current revenue of IMCD? | IMCD's last 12 months revenue is $6B. |
| What is the current revenue growth of IMCD? | IMCD revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of IMCD? | Current revenue multiple of IMCD is 1.4x. |
| What is the current EBITDA of IMCD? | IMCD's last 12 months EBITDA is $644M. |
| What is IMCD's EBITDA margin? | IMCD's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of IMCD? | Current EBITDA multiple of IMCD is 12.3x. |
| What is the current FCF of IMCD? | IMCD's last 12 months FCF is $373M. |
| What is IMCD's FCF margin? | IMCD's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of IMCD? | Current FCF multiple of IMCD is 21.3x. |
| How many companies IMCD has acquired to date? | As of June 2026, IMCD has acquired 35 companies. |
| What was the largest acquisition by IMCD? | $154M acquisition of Tillmanns on 27th August 2025 was the largest M&A IMCD has done to date. |
| What companies IMCD acquired? | IMCD acquired Tillmanns, Sachs Chemical, KOI Products Solutions & Engineering, Mutchler, Bretano, Feza Kimya Ic Ve Dis Ticaret Anonim Sirketi, O&3, Valuetree, The E.T. Horn Company, Neuvendis SpA, and 25 other companies. |
| In how many companies IMCD has invested to date? | IMCD hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to IMCD
Lists including IMCD
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.



